In vitro susceptibility of respiratory pathogens to levofloxacin and other antibiotic agents;Susceptibilidad in vitro de patógenos respiratorios a levofloxacina y otros antimicrobianos

Revista Chilena de Infectologia

Volumn 17, Issue 1, 2000, Pages 18-24

  Giglio M , M Soledad ^a,b,d   Porte T , Lorena ^a   Herve E , Beatrice ^c   Ulloa F , M Teresa ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Aventis   (Chile)

^c Hospital San Juan de Dios   (Chile)

^d NONE   (Chile)

Author keywords

Haemophilus influenzae; In vitro activity; Levofloxacin; Moraxella catarrhalis; Streptococcus pneumoniae

Indexed keywords

EID: 0008129863     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. BAQUERO F, BARRETT J F, COURVALIN P, MORRISEY I, PIDDOCK I, NOVICK. Epidemiology and mechanisms of resistance among respiratory tract pathogens Clin Microbiol Infect 1998; 4: 19-26.
2. JULIET C, GIGLIO M S, CAMPONOVO R. Sensibilidad de S. pneumoniae y su importancia clínica. Rev Méd Chile 1987; 115: 852-7.
3. GIGLIO M S, CAMPONOVO R, PINTO C ME. Sensibilidad de Streptococcus pneumoniae a penicilina y otros antimicrobianos Libro de Resúmenes, VI Congreso Panamericano de Infectología y X Congreso Chileno de Infectología, Mayo 1993 Viña del Mar, Chile.
4. PALAVECINO E, CAMPONOVO R, GIGLIO M S, APPELBAUM P, JACOBS M. Alta prevalencia de S. pneumoniae resistente a antibióticos. Libro de Resúmenes, XV Congreso Chileno de Infectología, Agosto 1998, Santiago Chile.
5. BERK S L, KALBFLEISCH J H. The Alexander Project Collaborative Group. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. J. Antimicrob Chemother 1996; 38 (Suppl A): 85-96.
6. th ed. Approved Standard NCCLS Document M100-S(8) Wayne, PA, 1998.
7. GOLSDTEIN F, BRYSKIER A, APPELBAUM P C et al. The etiology of respiratory tract infections and the antibacterial activity of fluorquinolones and other oral antibacterial agents against respiratory pathogens. Clin Microbiol Infect 1998; 4: 8-18.
8. THOMSOM K S, CHARTRAND S A, SANDERS C C, BLOCK S L. In vitro activity of levofloxacin against antibiotic-resistant Streptococcus pneumoniae. Abstracts of 20 International Congress of Chemotherapy, P018, Sydney 1997.
9. THORNSBERRY C, OGILVIE P, KAHN J, MAURIZ Y Surveillance of antimicrobial resistance in Streptococcus pneumonia, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. Diagn Microbiol Infect Dis 1997; 29: 249-57.
10. 10.- PALAVECINO E, APPELBAUM P, JACOBS M. Streptococcus pneumoniae resistente a antibióticos: Aspectos microbiológicos y clínicos. Rev Chil Infect 1997; 14: 7-27.
11. 11.- BIEDENBACH D J, JONES R N. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of Streptococci. Diagn Microbiol Infect Dis 1996; 25: 47-51.
12. 12.- HOOGKRAMP-KORSTANJE J A A. In vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against Gram-positive and Gram-negative pathogens from respiratory tract infections. J Antimicrob Chemother 1997; 40: 427-31.
13. 13.- MORRISSEY G J. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae. J Antimicrob Chemother 1997; 39: 719-23.
14. 14.- CASELLAS J M, TOME G, FARINATI A E, GILARDONI M, PAGNIEZ G, IVANOVIC S. In vitro activities of levofloxacin, trovafloxacin, gatifloxacin, moxifloxacin and sparfloxacin against 118 isolates from adults community acquired lower respiratory tract infections with reduced susceptibility to commonly used antibiotics. 8th International Congress on Infectious Diseases, Boston 1998.
15. 15.- DERECOLA A, BUTLER D L, KAPLAN R L, MILLER L A, POUPARD J A. A 5-year surveillance study of 44,691 isolates of Haemophilus influenzae project Beta-Alert 1993-1997. Antimicrob Agents Chemother 1999; 43: 185-6.
16. 16.- CASELLAS J M, GILARDONI M, TOME G et al. Comparative in- vitro activity of levofloxacin against isolates of bacteria from adult patients with community- acquired lower respiratory tract infections. J Antimicrobial Chemother 1999; 43 (Suppl): S37-42.
17. 17.- Boletín de Vigilancia Epidemiológica de sensibilidad antimicrobiana de algunos agentes bacterianos de importancia clínica. Instituto de Salud Pública, 1997.
18. 18.- CAMPONOVO R, SEPULVEDA A, FIGUEROA O, HEITMANN I. Resistencia a eritromicina de Streptococcus pyogenes. Libro de Resúmenes, XV Congreso Chileno de Infectología, Agosto 1998 Santiago, Chile.